Literature DB >> 13664786

The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders.

A P FLETCHER, S SHERRY, N ALKJAERSIG, F E SMYRNIOTIS, S JICK.   

Abstract

Entities:  

Keywords:  MYOCARDIAL INFARCT/therapy; STREPTODORNASE AND STREPTOKINASE/therapeutic use; THROMBOEMBOLISM/therapy

Mesh：

Substances：

Year:  1959        PMID： 13664786      PMCID： PMC293258          DOI： 10.1172/JCI103887

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  6 in total

1.  The mechanism of clot dissolution by plasmin.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

2.  The maintenance of a sustained thrombolytic state in man. I. Induction and effects.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

3.  The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy.

Authors:  A P FLETCHER; N ALKJAERSIG; F E SMYRNIOTIS; S SHERRY
Journal:  Trans Assoc Am Physicians       Date:  1958

4.  Fibrinolytic (plasmin) therapy of experimental coronary thrombi with alteration of the evolution of myocardial infarction.

Authors:  P RUEGSEGGER; I NYDICK; R C HUTTER; A H FREIMAN; N U BANG; E E CLIFFTON; J S LADUE
Journal:  Circulation       Date:  1959-01       Impact factor: 29.690

5.  An approach to intravascular fibrinolysis in man.

Authors:  S SHERRY; A P FLETCHER; N ALKAJERSIG; F E SMYRNIOTIS
Journal:  Trans Assoc Am Physicians       Date:  1957

6.  Intravenous trypsin in experimental myocardial infarction.

Authors:  C M AGRESS; H I JACOBS; M J BINDER; W G CLARK; L KAPLAN; M LEDERER; H F GLASSNE
Journal:  Circ Res       Date:  1954-09       Impact factor: 17.367
  6 in total
  27 in total

1.  THROMBOLYTIC THERAPY.

Authors:  A S DOUGLAS; G P MCNICOL
Journal:  Proc R Soc Med       Date:  1964-07

2.  Treatment of peripheral arterial occlusion by streptokinase perfusion.

Authors:  G P MCNICOL; W REID; W H BAIN; A S DOUGLAS
Journal:  Br Med J       Date:  1963-06-08

3.  Thrombolytic therapy.

Authors:  G P MCNICOL
Journal:  Proc R Soc Med       Date:  1963-05

4.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

5.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

6.  The maintenance of a sustained thrombolytic state in man. I. Induction and effects.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

7.  Studies on the thrombolytic activity of human plasma.

Authors:  W D SAWYER; A P FLETCHER; N ALKJAERSIN; S SHERRY
Journal:  J Clin Invest       Date:  1960-02       Impact factor: 14.808

8.  Behavior in the circulation of the radioactive pulmonary embolus and its application to the study of fibrinolytic enzymes.

Authors:  M HUME; W W GLENN; T GRILLO
Journal:  Ann Surg       Date:  1960-04       Impact factor: 12.969

9.  Atherosclerosis: past, present, and future.

Authors:  R J Hall
Journal:  Tex Heart Inst J       Date:  1990

10.  Feasibility of Adequate Thrombolytic Therapy with Streptokinase in Peripheral Arterial Occlusions: II. Changes in Peripheral Blood and Thrombolysis in vivo.

Authors:  A Amery; J Vermylen; M Verstraete
Journal:  Br Med J       Date:  1963-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.